MedTrace Logo

A Pilot Trial of Triheptanoin for the Preventive Treatment of Migraine

NCT02784847 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2016-05-27

No results posted yet for this study

Summary

A pilot trial of triheptanoin, a natural compound able to promote anaplerotic mitochondrial metabolism, for the preventative treatment of migraine.

Conditions

Interventions

DRUG

Triheptanoin

Triheptanoin oil administered three times per day during meals at a total dose 1mg/kg/day for 3 months

Sponsors & Collaborators

  • University of Liege

    lead OTHER

Principal Investigators

  • Jean Schoenen, MD,PhD · University Hospital Liège

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-11-30
Completion
2016-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02784847 on ClinicalTrials.gov